Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Total article views   HTML views PDF downloads Totals
31,298 Dovepress* 28,159+ 1,332 29,491
PubMed Central* 3,139 672 3,811
Totals 31,298 2,004 33,302
*Since 24 September 2018
Total mentioned Facebook Delicious Reddit Twitter Others
18 1 0 0 6 11

View citations on PubMed Central and Google Scholar